TNF-α inhibitors may reduce mortality and inflammation in moderate-to-severe COVID-19 cases. However, further studies are needed to confirm their effectiveness and safety.
The post Inflammatory Modulation in Severe COVID-19 first appeared on Physician’s Weekly.
